{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:31:48Z","timestamp":1791325908489,"version":"4.3.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11011-021-00808-2","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T02:02:46Z","timestamp":1628474566000},"page":"1545-1557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Gut brain axis: an insight into microbiota role in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Sara Ayman","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrouk","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhameed","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihan","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura A. M.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-0273","authenticated-orcid":false,"given":"Mohamed","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"808_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, Scheperjans F (2019) Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44:691\u2013707","journal-title":"EBioMedicine"},{"key":"808_CR2","doi-asserted-by":"crossref","unstructured":"Alecu I, Bennett SAL (2019) 'Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front Neurosci 13(328)","DOI":"10.3389\/fnins.2019.00328"},{"key":"808_CR3","doi-asserted-by":"publisher","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol 15(12):1257\u20131272. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7","DOI":"10.1016\/S1474-4422(16)30230-7"},{"issue":"2","key":"808_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/1673-5374.290896","volume":"16","author":"J Baizabal-Carvallo","year":"2021","unstructured":"Baizabal-Carvallo J (2021) Gut microbiota: a potential therapeutic target for Parkinsons disease. Neural Regen Res 16(2):287. https:\/\/doi.org\/10.4103\/1673-5374.290896","journal-title":"Neural Regen Res"},{"key":"808_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.psyneuen.2017.07.487","volume":"85","author":"TJ Barry","year":"2017","unstructured":"Barry TJ, Murray L, Fearon P, Moutsiana C, Johnstone T, Halligan SL (2017) Amygdala volume and hypothalamic-pituitary-adrenal axis reactivity to social stress. Psychoneuroendocrinology 85:96\u201399","journal-title":"Psychoneuroendocrinology"},{"key":"808_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/S415","volume":"6","author":"JM Beitz","year":"2014","unstructured":"Beitz JM (2014) Parkinson\u2019s disease: a review. Front Biosci (schol Ed) 6:65\u201374","journal-title":"Front Biosci (schol Ed)"},{"key":"808_CR7","doi-asserted-by":"crossref","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP (2016) Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses. Parkinsonism Relat Disord 23:1\u20139","DOI":"10.1016\/j.parkreldis.2015.12.008"},{"issue":"2","key":"808_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"key":"808_CR9","unstructured":"Britannica TE (2018) Digestive nerve plexus"},{"key":"808_CR10","doi-asserted-by":"crossref","unstructured":"Butterworth AD, Thomas AG, Akobeng AK (2008) Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008(3):CD006634-CD006634","DOI":"10.1002\/14651858.CD006634.pub2"},{"issue":"3","key":"808_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000443362","volume":"34","author":"G Cammarota","year":"2016","unstructured":"Cammarota G, Pecere S, Ianiro G, Masucci L, Curr\u00f2 D (2016) Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis 34(3):279\u2013285","journal-title":"Dig Dis"},{"issue":"2","key":"808_CR12","first-page":"117","volume":"57","author":"E Cassani","year":"2011","unstructured":"Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L, Barichella M (2011) Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol Dietol 57(2):117\u2013121","journal-title":"Minerva Gastroenterol Dietol"},{"key":"808_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.619354","author":"Z-J Chen","year":"2021","unstructured":"Chen Z-J, Liang C-Y, Yang L-Q, Ren S-M, Xia Y-M, Cui L et al (2021) Association of Parkinson\u2019s disease with microbes and microbiological therapy. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2021.619354","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"808_CR14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N, Foulger LH, Mackenzie M, Huan T, Finlay BB, Appel-Cresswell S (2020) Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov Disord 35(7):1208\u20131217","journal-title":"Mov Disord"},{"key":"808_CR15","doi-asserted-by":"crossref","unstructured":"Costa M, Brookes SJ, Hennig GW (2000) Anatomy and physiology of the enteric nervous system. Gut 47 (Suppl 4):iv15\u2013iv26","DOI":"10.1136\/gut.47.suppl_4.iv15"},{"issue":"10","key":"808_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701\u2013712. https:\/\/doi.org\/10.1038\/nrn3346","journal-title":"Nat Rev Neurosci"},{"key":"808_CR17","doi-asserted-by":"crossref","unstructured":"Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y (2019) Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 8(3):92","DOI":"10.3390\/foods8030092"},{"issue":"4","key":"808_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1523-5378.2010.00768.x","volume":"15","author":"SM Dobbs","year":"2010","unstructured":"Dobbs SM, Dobbs RJ, Weller C, Charlett A, Bjarnason IT, Lawson AJ, Letley D, Harbin L, Price AB, Ibrahim MA, Oxlade NL, Bowthorpe J, Leckstroem D, Smee C, Plant JM, Peterson DW (2010) Differential effect of Helicobacter pylori eradication on time-trends in brady\/hypokinesia and rigidity in idiopathic parkinsonism. Helicobacter 15(4):279\u2013294","journal-title":"Helicobacter"},{"key":"808_CR19","doi-asserted-by":"crossref","unstructured":"Doroftei B, Ilie OD, Cojocariu RO, Ciobica A, Maftei R, Grab D, Anton E, McKenna J, Dhunna N, Simionescu G (2020) Minireview exploring the biological cycle of vitamin B3 and its influence on oxidative stress: further molecular and clinical aspects. Molecules 25(15)","DOI":"10.3390\/molecules25153323"},{"issue":"25","key":"808_CR20","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR et al (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinsons disease. Proc Natl Acad Sci 98(25):14669\u201314674. https:\/\/doi.org\/10.1073\/pnas.251341998","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"808_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5056\/jnm19044","volume":"25","author":"SK Dutta","year":"2019","unstructured":"Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP (2019) Parkinson\u2019s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neurogastroenterol Motil 25(3):363\u2013376","journal-title":"J Neurogastroenterol Motil"},{"issue":"6","key":"808_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/mds.28004","volume":"35","author":"M Elfil","year":"2020","unstructured":"Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM (2020) Implications of the gut microbiome in Parkinson\u2019s disease. Mov Disord 35(6):921\u2013933","journal-title":"Mov Disord"},{"issue":"1","key":"808_CR23","first-page":"51","volume":"40","author":"X Fang","year":"2019","unstructured":"Fang X (2019) Microbial treatment: the potential application for Parkinson\u2019s disease. Neurol Sci off J Ital Neurol Soc Ital Soc Clin Neurophysiol 40(1):51\u201358","journal-title":"Neurol Sci off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"808_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","volume":"6","author":"S Fanning","year":"2020","unstructured":"Fanning S, Selkoe D, Dettmer U (2020) Parkinson\u2019s disease: proteinopathy or lipidopathy? NPJ Parkinsons Dis 6:3","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"808_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, Barbaro F, Piano C, Fortuna S, Tortora A, Di Giacopo R, Campanale M, Gigante G, Lauritano EC, Navarra P, Marconi S, Gasbarrini A, Bentivoglio AR (2013) The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord 28(9):1241\u20131249","journal-title":"Mov Disord"},{"issue":"44","key":"808_CR26","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1523\/JNEUROSCI.1672-18.2018","volume":"38","author":"CT Fields","year":"2018","unstructured":"Fields CT, Sampson TR, Bruce-Keller AJ, Kiraly DD, Hsiao EY, de Vries GJ (2018) Defining dysbiosis in disorders of movement and motivation. J Neurosci 38(44):9414","journal-title":"J Neurosci"},{"key":"808_CR27","doi-asserted-by":"crossref","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PloS ONE 6(12):e28032","DOI":"10.1371\/journal.pone.0028032"},{"key":"808_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","volume":"817","author":"JB Furness","year":"2014","unstructured":"Furness JB, Callaghan BP, Rivera LR, Cho HJ (2014) The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol 817:39\u201371","journal-title":"Adv Exp Med Biol"},{"issue":"17","key":"808_CR29","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.3390\/ijms20174121","volume":"20","author":"P Gazerani","year":"2019","unstructured":"Gazerani P (2019) Probiotics for Parkinson\u2019s disease. Int J Mol Sci 20(17):4121","journal-title":"Int J Mol Sci"},{"key":"808_CR30","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/CIA.S106284","volume":"11","author":"D Georgescu","year":"2016","unstructured":"Georgescu D, Ancusa OE, Georgescu LA, Ionita I, Reisz D (2016) Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: is there hope? Clin Interv Aging 11:1601\u20131608","journal-title":"Clin Interv Aging"},{"issue":"7","key":"808_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/arclin\/acx091","volume":"32","author":"SJ Getz","year":"2017","unstructured":"Getz SJ, Levin B (2017) Cognitive and neuropsychiatric features of early Parkinson\u2019s disease. Arch Clin Neuropsychol 32(7):769\u2013785","journal-title":"Arch Clin Neuropsychol"},{"issue":"2","key":"808_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert M, Masuda-Suzukake M, Falcon B (2017) Like prions: the propagation of aggregated tau and \u03b1-synuclein in neurodegeneration. Brain 140(2):266\u2013278","journal-title":"Brain"},{"key":"808_CR33","doi-asserted-by":"publisher","first-page":"41755","DOI":"10.1038\/srep41755","volume":"7","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga F, Soc\u00edas SB, \u00c1vila CL, Torres-Bugeau CM, Barbosa LR, Binolfi A, Sep\u00falveda-D\u00edaz JE, Del-Bel E, Fernandez CO, Papy-Garcia D, Itri R, Raisman-Vozari R, Cheh\u00edn RN (2017) Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species. Sci Rep 7:41755. https:\/\/doi.org\/10.1038\/srep41755","journal-title":"Sci Rep"},{"issue":"4","key":"808_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/metabo8040071","volume":"8","author":"SF Graham","year":"2018","unstructured":"Graham SF, Rey NL, Ugur Z, Yilmaz A, Sherman E, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P (2018) Metabolomic profiling of bile acids in an experimental model of prodromal parkinson\u2019s disease. Metabolites 8(4):71","journal-title":"Metabolites"},{"key":"808_CR35","doi-asserted-by":"crossref","unstructured":"Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M (2015) Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in parkinson\u2019s disease. PLOS ONE 10(11):e0142164","DOI":"10.1371\/journal.pone.0142164"},{"key":"808_CR36","doi-asserted-by":"crossref","unstructured":"Hasuike Y, Endo T, Koroyasu M, Matsui M, Mori C, Yamadera M, Fujimura H, Sakoda S (2020) Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease. Med Hypotheses 134:109436","DOI":"10.1016\/j.mehy.2019.109436"},{"key":"808_CR37","doi-asserted-by":"crossref","unstructured":"Heintz-Buschart A, Pandey U, Wicke T, Sixel-D\u00f6ring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P (2018) The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 33(1):88\u201398","DOI":"10.1002\/mds.27105"},{"issue":"5","key":"808_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749","journal-title":"Mov Disord"},{"issue":"8","key":"808_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506\u2013514","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"808_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H, Carroll C (2014) Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol 127(2):235\u2013241","journal-title":"Acta Neuropathol"},{"key":"808_CR41","doi-asserted-by":"crossref","unstructured":"Hopfner F, K\u00fcnstner A, M\u00fcller SH, K\u00fcnzel S, Zeuner KE, Margraf NG, Deuschl G, Baines JF, Kuhlenb\u00e4umer G (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41\u201345","DOI":"10.1016\/j.brainres.2017.04.019"},{"key":"808_CR42","doi-asserted-by":"crossref","unstructured":"Hsieh TH, Kuo CW, Hsieh KH, Shieh MJ, Peng CW, Chen YC, Chang YL, Huang YZ, Chen CC, Chang PK, Chen KY, Chen HY (2020) Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson's disease. Brain Sci 10(4)","DOI":"10.3390\/brainsci10040206"},{"issue":"26","key":"808_CR43","doi-asserted-by":"publisher","first-page":"e16163","DOI":"10.1097\/MD.0000000000016163","volume":"98","author":"H Huang","year":"2019","unstructured":"Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y (2019) Fecal microbiota transplantation to treat Parkinson\u2019s disease with constipation: a case report. Medicine 98(26):e16163\u2013e16163","journal-title":"Medicine"},{"issue":"1","key":"808_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang O (2013) Role of oxidative stress in Parkinson\u2019s disease. Exp Neurobiol 22(1):11\u201317","journal-title":"Exp Neurobiol"},{"issue":"10","key":"808_CR45","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u20131360","journal-title":"Mov Disord"},{"key":"808_CR46","doi-asserted-by":"crossref","unstructured":"Kilzheimer A, Hentrich T, Burkhardt S, Schulze-Hentrich JM (2019) The challenge and opportunity to diagnose Parkinson's disease in midlife. Front Neurol, 10(1328)","DOI":"10.3389\/fneur.2019.01328"},{"issue":"4","key":"808_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cpet.2013.08.005","volume":"8","author":"M Kleinman","year":"2013","unstructured":"Kleinman M, Frank S (2013) Epidemiology and clinical diagnosis of Parkinson disease. PET Clin 8(4):447\u2013458","journal-title":"PET Clin"},{"issue":"6","key":"808_CR48","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165(6):1332\u20131345","journal-title":"Cell"},{"issue":"6","key":"808_CR49","first-page":"859","volume":"67","author":"PC Konturek","year":"2016","unstructured":"Konturek PC, Koziel J, Dieterich W, Haziri D, Wirtz S, Glowczyk I, Konturek K, Neurath MF, Zopf Y (2016) Successful therapy of Clostridium difficile infection with fecal microbiota transplantation. J Physiol Pharmacol 67(6):859\u2013866","journal-title":"J Physiol Pharmacol"},{"issue":"4","key":"808_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E (2017) Dysbiosis and the immune system. Nat Rev Immunol 17(4):219\u2013232","journal-title":"Nat Rev Immunol"},{"key":"808_CR51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuroscience.2015.09.033","volume":"310","author":"S Liang","year":"2015","unstructured":"Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F (2015) Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310:561\u2013577","journal-title":"Neuroscience"},{"key":"808_CR52","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-pharmtox-010919-023628","volume":"60","author":"C Long-Smith","year":"2020","unstructured":"Long-Smith C, O\u2019Riordan KJ, Clarke G, Stanton C, Dinan TG, Cryan JF (2020) Microbiota-gut-brain axis: new therapeutic opportunities. Annu Rev Pharmacol Toxicol 60:477\u2013502","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"808_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/17474124.2018.1503946","volume":"12","author":"LR Lopetuso","year":"2018","unstructured":"Lopetuso LR, Napoli M, Rizzatti G, Scaldaferri F, Franceschi F, Gasbarrini A (2018) Considering gut microbiota disturbance in the management of Helicobacter pylori infection. Exp Rev Gastroenterol Hepatol 12(9):899\u2013906","journal-title":"Exp Rev Gastroenterol Hepatol"},{"issue":"3","key":"808_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biom11030433","volume":"11","author":"M Lorente-Pic\u00f3n","year":"2021","unstructured":"Lorente-Pic\u00f3n M, Laguna A (2021) New avenues for Parkinson\u2019s disease therapeutics: disease-modifying strategies based on the gut microbiota. Biomolecules 11(3):433. https:\/\/doi.org\/10.3390\/biom11030433","journal-title":"Biomolecules"},{"issue":"9","key":"808_CR55","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","volume":"267","author":"M Lubomski","year":"2020","unstructured":"Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM (2020) Parkinson\u2019s disease and the gastrointestinal microbiome. J Neurol 267(9):2507\u20132523","journal-title":"J Neurol"},{"issue":"1","key":"808_CR56","first-page":"117","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M, Kubera M, Leunis JC (2008) The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29(1):117\u2013124","journal-title":"Neuro Endocrinol Lett"},{"key":"808_CR57","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","volume":"10","author":"L Magistrelli","year":"2019","unstructured":"Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M, Comi C (2019) Probiotics may have beneficial effects in parkinson\u2019s disease: in vitro evidence. Front Immunol 10:969\u2013969","journal-title":"Front Immunol"},{"issue":"3","key":"808_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/JPD-181327","volume":"8","author":"DJ McGee","year":"2018","unstructured":"McGee DJ, Lu XH, Disbrow EA (2018) Stomaching the possibility of a pathogenic role for helicobacter pylori in parkinson\u2019s Disease. J Parkinsons Dis 8(3):367\u2013374","journal-title":"J Parkinsons Dis"},{"key":"808_CR59","doi-asserted-by":"crossref","unstructured":"Miraglia F, Colla E (2019) Microbiome, Parkinson's disease and molecular mimicry. Cells 8(3)","DOI":"10.3390\/cells8030222"},{"issue":"37","key":"808_CR60","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 21(37):10609\u201310620","journal-title":"World J Gastroenterol"},{"key":"808_CR61","doi-asserted-by":"crossref","unstructured":"Myers K (2019) Gut\/brain axis and its role in Parkinson\u2019s disease progression. unpublished thesis (Creative Components), Iowa State University","DOI":"10.31274\/cc-20240624-807"},{"issue":"2","key":"808_CR62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000502292","volume":"19","author":"N Nag","year":"2019","unstructured":"Nag N, Jelinek GA (2019) A narrative review of lifestyle factors associated with Parkinson\u2019s disease risk and progression. Neurodegener Dis 19(2):51\u201359","journal-title":"Neurodegener Dis"},{"issue":"1","key":"808_CR63","doi-asserted-by":"crossref","first-page":"e13726","DOI":"10.1111\/nmo.13726","volume":"32","author":"SM O'Donovan","year":"2020","unstructured":"O\u2019Donovan SM, Crowley EK, Brown JR, O\u2019Sullivan O, O\u2019Leary OF, Timmons S, Nolan YM, Clarke DJ, Hyland NP, Joyce SA, Sullivan AM, O\u2019Neill C (2020) Nigral overexpression of \u03b1-synuclein in a rat Parkinson\u2019s disease model indicates alterations in the enteric nervous system and the gut microbiome. Neurogastroenterol Motil 32(1):e13726","journal-title":"Neurogastroenterol Motil"},{"key":"808_CR64","doi-asserted-by":"crossref","unstructured":"Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D, Gasbarrini A (2012) Impact of Lactobacillus reuteri supplementation on anti-helicobacter pylori levofloxacin-based second-line therapy. Gastroenterol Res Pract 740381","DOI":"10.1155\/2012\/740381"},{"issue":"7","key":"808_CR65","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/cells8070659","volume":"8","author":"Y Oligschlaeger","year":"2019","unstructured":"Oligschlaeger Y, Yadati T, Houben T, Oliv\u00e1n CMC, Shiri-Sverdlov R (2019) Inflammatory bowel disease: a stressed, \u201cgut\/feeling.\u201d Cells 8(7):659. https:\/\/doi.org\/10.3390\/cells8070659","journal-title":"Cells"},{"issue":"12","key":"808_CR66","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics\u2014a review. J Food Sci Technol 52(12):7577\u20137587. https:\/\/doi.org\/10.1007\/s13197-015-1921-1","journal-title":"J Food Sci Technol"},{"key":"808_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","volume":"38","author":"A Parashar","year":"2017","unstructured":"Parashar A, Udayabanu M (2017) Gut microbiota: implications in Parkinson\u2019s disease. Parkinsonism Relat Disord 38:1\u20137","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"808_CR68","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jnc.13595","volume":"139","author":"W Peelaerts","year":"2016","unstructured":"Peelaerts W, Baekelandt V (2016) \u0251-Synuclein strains and the variable pathologies of synucleinopathies. J Neurochem 139(Suppl 1):256\u2013274","journal-title":"J Neurochem"},{"key":"808_CR69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","volume":"817","author":"P Perez-Pardo","year":"2017","unstructured":"Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD (2017) The gut-brain axis in Parkinson\u2019s disease: possibilities for food-based therapies. Eur J Pharmacol 817:86\u201395","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"808_CR70","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov VA, Saltykova IV, Zhukova IA, Alifirova VM, Zhukova NG, Dorofeeva YB, Tyakht AV, Kovarsky BA, Alekseev DG, Kostryukova ES, Mironova YS, Izhboldina OP, Nikitina MA, Perevozchikova TV, Fait EA, Babenko VV, Vakhitova MT, Govorun VM, Sazonov AE (2017) Analysis of gut microbiota in patients with Parkinson\u2019s disease. Bull Exp Biol Med 162(6):734\u2013737","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"808_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s100720170061","volume":"22","author":"M Pierantozzi","year":"2001","unstructured":"Pierantozzi M, Pietroiusti A, Sancesario G, Lunardi G, Fedele E, Giacomini P, Frasca S, Galante A, Marciani MG, Stanzione P (2001) Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson\u2019s disease patients. Neurol Sci 22(1):89\u201391","journal-title":"Neurol Sci"},{"key":"808_CR72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","volume":"65","author":"D Pietrucci","year":"2019","unstructured":"Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, Biocca S, Stefani A, Desideri A (2019) Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients. Parkinsonism Relat Disord 65:124\u2013130","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"808_CR73","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/brainsci10040242","volume":"10","author":"D Pietrucci","year":"2020","unstructured":"Pietrucci D, Teofani A, Unida V, Cerroni R, Biocca S, Stefani A, Desideri A (2020) Can gut microbiota be a good predictor for Parkinson\u2019s disease? A machine learning approach. Brain Sci 10(4):242","journal-title":"Brain Sci"},{"issue":"2","key":"808_CR74","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/mds.26060","volume":"30","author":"B Pinter","year":"2015","unstructured":"Pinter B, Diem-Zangerl A, Wenning GK, Scherfler C, Oberaigner W, Seppi K, Poewe W (2015) Mortality in Parkinson\u2019s disease: a 38-year follow-up study. Mov Disord 30(2):266\u2013269","journal-title":"Mov Disord"},{"issue":"12","key":"808_CR75","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1007\/s00415-013-7089-6","volume":"260","author":"KE Rahne","year":"2013","unstructured":"Rahne KE, Tagesson C, Nyholm D (2013) Motor fluctuations and Helicobacter pylori in Parkinson\u2019s disease. J Neurol 260(12):2974\u20132980","journal-title":"J Neurol"},{"issue":"6","key":"808_CR76","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469-1480.e12","journal-title":"Cell"},{"issue":"6","key":"808_CR77","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/WCO.0000000000000389","volume":"29","author":"F Scheperjans","year":"2016","unstructured":"Scheperjans F (2016) Gut microbiota, 1013 new pieces in the Parkinson\u2019s disease puzzle. Curr Opin Neurol 29(6):773\u2013780","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"808_CR78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358","journal-title":"Mov Disord"},{"issue":"2","key":"808_CR79","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/gutjnl-2016-312904","volume":"67","author":"C Schulz","year":"2018","unstructured":"Schulz C, Sch\u00fctte K, Koch N, Vilchez-Vargas R, Wos-Oxley ML, Oxley APA, Vital M, Malfertheiner P, Pieper DH (2018) The active bacterial assemblages of the upper GI tract in individuals with and without <em>Helicobacter<\/em> infection. Gut 67(2):216","journal-title":"Gut"},{"issue":"3","key":"808_CR80","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","volume":"164","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164(3):337\u2013340","journal-title":"Cell"},{"issue":"6","key":"808_CR81","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord 27(6):716\u2013719","journal-title":"Mov Disord"},{"key":"808_CR82","doi-asserted-by":"crossref","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol 11(25)","DOI":"10.3389\/fendo.2020.00025"},{"key":"808_CR83","unstructured":"Slikker W, Paule, Merle G,Wang C (2018) Handbook of developmental neurotoxicology, Second Edition ed. Academic Press."},{"issue":"2","key":"808_CR84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.smim.2006.10.002","volume":"19","author":"K Smith","year":"2007","unstructured":"Smith K, McCoy KD, Macpherson AJ (2007) Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19(2):59\u201369","journal-title":"Semin Immunol"},{"key":"808_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-405941-2.00021-3","author":"MAC Stephens","year":"2014","unstructured":"Stephens MAC, Mccaul ME, Wand GS (2014) The potential role of glucocorticoids and the HPA axis in alcohol dependence. Neurobiol Alcohol Dependence. https:\/\/doi.org\/10.1016\/b978-0-12-405941-2.00021-3","journal-title":"Neurobiol Alcohol Dependence"},{"issue":"15","key":"808_CR86","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1021\/jm400161p","volume":"56","author":"T Stoilova","year":"2013","unstructured":"Stoilova T, Colombo L, Forloni G, Tagliavini F, Salmona M (2013) A new face for old antibiotics: tetracyclines in treatment of amyloidoses. J Med Chem 56(15):5987\u20136006. https:\/\/doi.org\/10.1021\/jm400161p","journal-title":"J Med Chem"},{"issue":"1","key":"808_CR87","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","volume":"373","author":"JA Steiner","year":"2018","unstructured":"Steiner JA, Quansah E, Brundin P (2018) The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res 373(1):161\u2013173","journal-title":"Cell Tissue Res"},{"issue":"6","key":"808_CR88","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P (2016) Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol 79(6):940\u2013949","journal-title":"Ann Neurol"},{"key":"808_CR89","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen YQ (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360","journal-title":"Brain Behav Immun"},{"key":"808_CR90","doi-asserted-by":"crossref","unstructured":"Sun Y, Zhang M, Chen C-C, Gillilland M, Sun X, El-Zaatari M, Huffnagle GB, Young VB, Zhang J, Hong S-C, Chang Y-M, Gumucio DL, Owyang C, Kao JY (2013) Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology 144(7):1478\u201387, 1487.e1\u20138","DOI":"10.1053\/j.gastro.2013.02.038"},{"issue":"4","key":"808_CR91","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, S\u00f8rensen HT (2015) Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol 78(4):522\u2013529","journal-title":"Ann Neurol"},{"issue":"3","key":"808_CR92","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, Oryan S, Mafi A, Asemi Z (2019) Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr 38(3):1031\u20131035","journal-title":"Clin Nutr"},{"key":"808_CR93","doi-asserted-by":"publisher","first-page":"109564","DOI":"10.1016\/j.mehy.2020.109564","volume":"137","author":"G Tern\u00e1k","year":"2020","unstructured":"Tern\u00e1k G, Kuti D, Kov\u00e1cs KJ (2020) Dysbiosis in Parkinson\u2019s disease might be triggered by certain antibiotics. Med Hypotheses 137:109564","journal-title":"Med Hypotheses"},{"issue":"8","key":"808_CR94","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (vienna) 124(8):901\u2013905","journal-title":"J Neural Transm (vienna)"},{"issue":"23","key":"808_CR95","doi-asserted-by":"publisher","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","volume":"294","author":"CL Ugalde","year":"2019","unstructured":"Ugalde CL, Lawson VA, Finkelstein DI, Hill AF (2019) The role of lipids in \u03b1-synuclein misfolding and neurotoxicity. J Biol Chem 294(23):9016\u20139028","journal-title":"J Biol Chem"},{"key":"808_CR96","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, Fa\u00dfbender K, Schwiertz A, Sch\u00e4fer KH (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"key":"808_CR97","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3389\/fneur.2019.01155","volume":"10","author":"D Yang","year":"2019","unstructured":"Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L (2019) The role of the gut microbiota in the Pathogenesis of Parkinson\u2019s disease. Front Neurol 10:1155\u20131155","journal-title":"Front Neurol"},{"issue":"6","key":"808_CR98","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30(6):492\u2013506","journal-title":"Cell Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00808-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-021-00808-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00808-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T22:35:49Z","timestamp":1725575749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-021-00808-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s11011-021-00808-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}